How many insider trades does FilingIQ track for DMRA?

FilingIQ tracks 8 Form 4 insider transactions for DMRA (Damora Therapeutics, Inc.), covering filings from Mar 23, 2026 onwards. 8 of those were filed in the last 90 days.

Are DMRA insiders net buyers or net sellers?

Across the full Form 4 history for DMRA, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DMRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DMRA in?

Damora Therapeutics, Inc. (DMRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.86B.

DMRA insider trading

Healthcare

Damora Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$1.86B

About Damora Therapeutics, Inc.

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Company website: galecto.com

DMRA insider activity at a glance

FilingIQ has scored 8 insider transactions for DMRA since Mar 23, 2026. The most recent filing in our index is dated Mar 30, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live DMRA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for DMRA?: FilingIQ tracks 8 Form 4 insider transactions for DMRA (Damora Therapeutics, Inc.), covering filings from Mar 23, 2026 onwards. 8 of those were filed in the last 90 days.
Are DMRA insiders net buyers or net sellers?: Across the full Form 4 history for DMRA, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DMRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DMRA in?: Damora Therapeutics, Inc. (DMRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.86B.

Methodology & sources

Every DMRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.